SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

The Federal Reserves rate hike is driving debate over SoFis exposure to higher funding costs, lending demand and credit risk versus potential benefits to its banking net-interest margins. Traders are divided, with many arguing the hike was already reflected in guidance and others warning that higher-for-longer rates could pressure the stock and fintech valuation.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation of topline Phase 3 HLP003 results is driving attention after Helus completed enrollment in its pivotal MDD study ahead of schedule, with data expected in Q4 2026. Traders are also reacting positively to the new CEO and reported insider buying, while others remain cautious about clinical-readout risk and potential dilution.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that states can regulate or ban sports-event contracts was viewed by traders as a regulatory win for DraftKings, potentially reducing competition from Kalshi and other prediction markets. The community remains divided, with some expecting stronger sportsbook economics while others note the ruling may face further appeals and could complicate DraftKings own prediction-market expansion.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA full approval of Fayuvi, Ultragenyxs gene therapy for Sanfilippo syndrome type A, is driving attention, with the company also receiving a Priority Review Voucher and preparing for commercialization. Traders are largely bullish on the new product and potential short covering, though some question the muted share-price reaction, limited patient population, adverse-effect monitoring, and Ultragenyxs cash burn.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing shares are drawing attention after CEO Kelly Ortberg said stabilizing 737 MAX production is taking longer than expected because of wing-production constraints, while also tempering expectations for a near-term China order and citing slower widebody ramp-up issues. Traders largely reacted bearishly with a sharp selloff, though bulls argue the move is an overreaction given Boeings backlog, deliveries, defense contracts and expected MAX 10 certification; potential SPEEA labor disruption remains an additional concern.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

The failed or contested Salad and Go site acquisition is a major focus, with traders debating whether Dutch Bros avoided an expensive deal or lost a key expansion opportunity. Attention is also driven by the sharp selloff and valuation compression in a high-PE consumer stock, with bulls citing strong growth, store expansion and busy locations while bears point to weaker discretionary spending, competition, higher rates and possible dilution speculation.

Generac Holdings, Inc. engages in the business of designing and manufacturing energy technology solutions. It operates under the Domestic and International segments. The Domestic segment includes the legacy Generac business and the acquisitions that are based in the United States and Canada. The International segment focuses on Generac business' Latin American export operations. The company was founded in 1959 and is headquartered in Waukesha, WI.

Generac Holdings Inc

Generacs long-term agreement to supply backup generators for Amazons data centers has shifted attention toward its role in AI infrastructure, with traders citing stronger backlog visibility and potential growth beyond its residential-generator business. The community is broadly bullish, though some traders are debating warrant-related dilution, profit-taking, and the sharp post-announcement pullback.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Management commentary on clearer Medicare reimbursement prospects for Tempuss tissue-scanning and liquid-biopsy tests is driving attention, reinforcing the commercial outlook for its diagnostics business. Traders are broadly bullish and discussing breakout and short-squeeze potential, while others cite insider selling, elevated valuation, and pullback risk.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Lennars latest earnings report missed expectations and included another reduction to its full-year home-delivery outlook, highlighting weaker orders, margin pressure, and housing affordability challenges from elevated mortgage rates. Traders are largely bearish on the homebuilder sector, though some are debating whether the weak results are already priced in after the stocks prolonged decline and surprisingly resilient price action.

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

Twist Bioscience shares are trending due to a combination of strong institutional interest, positive analyst sentiment, and optimism surrounding the company's synthetic DNA technology and expanding biopharma collaborations. However, conversation remains polarized as some traders express skepticism regarding the company's path to profitability and historical volatility, while others highlight a pending class-action settlement related to 2022 disclosures as a factor to monitor.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
